Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gansu Zhongshan Licorice Development is a specialized pharmaceutical and chemical manufacturer focused on the processing and extraction of licorice-based compounds. Located in Gansu Province, China, the company leverages local natural resources to produce high-quality active pharmaceutical ingredients (APIs) including glycyrrhizic acid, dipotassium glycyrrhizinate, and monoammonium glycyrrhizinate. These products serve as critical components in treatments for liver diseases, inflammatory conditions, and respiratory ailments, as well as in the formulation of skincare and food products. The company operates under strict GMP standards and exports its specialized extracts to various international markets. It is recognized as a leading enterprise in the industrialization of agriculture in the region, maintaining large-scale cultivation and production facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gansu Zhongshan Licorice Development.